Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Gastric Cancer

Free Subscription 02.11.2026 3 Anticancer Res 3 BMC Cancer 3 BMC Gastroenterol 1 BMC Surg 1 Cancer Lett 1 Curr Treat Options Oncol 3 Eur J Surg Oncol 1 J Clin Oncol 1 J Gastroenterol Hepatol 1 Oncol Rep 1 Surgery

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Res

1. SHIMIZU S, Matsunaga T, Takahashi S, Kuroda H, et al
   Association of Recurrence-free Interval With Survival After Recurrence in Gastric Cancer: A Multicenter Retrospective Study.
   Anticancer Res. 2026;46:6373-6382.
   PubMed         Abstract available
   
   
2. ENOMOTO M, Mazaki J, Kondo S, Sakurai T, et al
   Prognostic Value of Preoperative Platelet-to-Lymphocyte Ratio in Advanced Gastric Cancer After Curative Resection.
   Anticancer Res. 2026;46:6357-6372.
   PubMed         Abstract available
   
   
3. ISHIKAWA A, Takigawa H, Oka S
   High-resolution Spatial Transcriptomics Reveals Contrasting Tumor States in Two Early Gastric Cancers.
   Anticancer Res. 2026;46:6141-6154.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. DING SR, Li X, Dong X, Chen P, et al
   Exploration of plasma proteomic landscapes using Olink Reveal technology to identify biomarkers for early-stage/localized gastric cancer.
   BMC Cancer. 2026;26:1299.
   PubMed         Abstract available
   
   
5. MA Z, Huang N, Ren B, Wang T, et al
   Single-cell transcriptomic atlas of gastric cancer reveals malignant cell heterogeneity and nominates EMB as a candidate prognostic biomarker.
   BMC Cancer. 2026;26:1292.
   PubMed         Abstract available
   
   
6. ZHANG X, Sun C, Zhang X
   Single-cell and bulk transcriptome-based identification of myeloid-derived suppressor cell-associated immune evasion signatures and a prognostic model for gastric cancer.
   BMC Cancer. 2026;26:1298.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. FAN Q, Zhang R, Xu D, Wen F, et al
   Association of gut Fusobacteria abundance with peritoneal metastasis in gastric signet-ring cell carcinoma: a cross-sectional study.
   BMC Gastroenterol. 2026;26:698.
   PubMed         Abstract available
   
   
8. SAKHRI S, Ghorbeli E, Khemir A, Abidi F, et al
   Pseudo-peritoneal carcinomatosis: extensive endosalpingiosis mimicking metastatic dissemination in gastric cancer : a case report and literature review.
   BMC Gastroenterol. 2026;26:708.
   PubMed         Abstract available
   
   
9. ABDALLAH B, Barada K, Asmar NE
   Type III gastric neuroendocrine tumor associated with a hyperplastic polyp presenting with severe iron deficiency anemia: a case report.
   BMC Gastroenterol. 2026;26:714.
   PubMed         Abstract available
   
   

   
   BMC Surg

10. OSMAN IM, Peng S, Liu H, Zhen W, et al
    Neoadjuvant immunotherapy for locally advanced resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis.
    BMC Surg. 2026;26:719.
    PubMed         Abstract available
    
    

    
    Cancer Lett

11. ZHANG F, Chen G, Chen X, Liang C, et al
    Lymph node metastasis mapping after neoadjuvant immunochemotherapy in gastric and gastroesophageal junction cancer: A pooled analysis of 4 prospective clinical trials.
    Cancer Lett. 2026;661:218891.
    PubMed         Abstract available
    
    

    
    Curr Treat Options Oncol

12. SAGAWA T, Hirakawa M, Nagashima H, Fujikawa K, et al
    Treatment Options After Recurrence Following Perioperative Durvalumab Plus FLOT for Gastric and Gastroesophageal Junction Adenocarcinoma: A Biology-First Sequencing Framework.
    Curr Treat Options Oncol. 2026;27:50.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

13. WAHEED U, Burn A, Ribbits A, Faisal M, et al
    Early-onset oesophagogastric adenocarcinoma: Clinicopathological characteristics and outcomes from a ten-year tertiary centre experience: A retrospective cohort study.
    Eur J Surg Oncol. 2026;52:112067.
    PubMed         Abstract available
    
    
14. GREGERSEN JS, Solstad TU, Achiam MP, Olsen AA, et al
    Textbook outcome in esophagogastric oncological surgery and long-term survival - A systematic review and meta-analysis.
    Eur J Surg Oncol. 2026;52:112062.
    PubMed         Abstract available
    
    
15. EL BOUKILI I, Kepenekian V, Rousset P, Passot G, et al
    Sarcopenia and outcomes after CRS +/- HIPEC for gastric peritoneal metastases: no association with major morbidity and poorer survival in synchronous disease.
    Eur J Surg Oncol. 2026;52:112102.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

16. PENG Z, Wang J, Zhang Y, Li H, et al
    First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT).
    J Clin Oncol. 2026;44:3015-3025.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

17. YEOH KG
    Metaplasia and the Origins of Gastric Cancer-Implications for Screening and Surveillance.
    J Gastroenterol Hepatol. 2026 Oct 23. doi: 10.1111/jgh.70825.
    PubMed         Abstract available
    
    

    
    Oncol Rep

18. YE YW, Hu S, Shi YQ, Zhang XF, et al
    [Corrigendum] Combination of the FGFR4 inhibitor PD173074 and 5?fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
    Oncol Rep. 2026;56:209.
    PubMed         Abstract available
    
    

    
    Surgery

19. ROSENTHAL RJ
    Beyond the textbook: What defines quality in modern gastric cancer surgery?
    Surgery. 2026;199:110579.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum